American Healthcare REIT (AHR) Insider III Buys 2,594 Shares
Insider trading shows confidence in American Healthcare REIT as Smith Wilbur III purchases shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Smith Wilbur III bought 2,594 shares of American Healthcare REIT, Inc. ($AHR) on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $AHR is up 7.6% after 1 week, up 15.2% after 1 month and up 7.3% to date (from the $49.62 close on Jun 24, 2026).
AHR
American Healthcare REIT, Inc.
Key Points
- On June 24, 2026, Smith Wilbur III bought 2,594 shares of American Healthcare REIT, Inc. (AHR) at a price of $51.00 per share.
- The stock is currently trading at $51.00, down from a previous close of $52.15, and has a 52-week range between $40.00 and $58.70.
- Analysts have a consensus 'strong buy' rating for AHR, with a target mean price of $64.40.
Get $AHR trade alerts by text
We text you when insiders, Congress or big funds trade $AHR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated American Healthcare REIT, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at American Healthcare REIT, Inc.
On June 24, 2026, Smith Wilbur III bought 2,594 shares of American Healthcare REIT, Inc. (AHR) on the NYSE. This purchase occurred at a price of $51.00 per share. The total value of this transaction was not disclosed.
Other Insider Activity
On the same day, multiple insiders made significant transactions. Mark Foster, EVP, GC & Secretary, sold 2,500 shares at an average price of $48.58, totaling about $121,450. Other insiders, including Mathieu Streiff, Valerie Richardson, Marvin O'Quinn, Dianne Hurley, and Brian Flornes, each bought 2,594 shares, but the prices for these transactions were not disclosed.
How American Healthcare REIT, Inc. Stock Has Traded
American Healthcare REIT's stock is currently priced at $51.00, which is slightly below its previous close of $52.15. The shares have traded between $40.00 and $58.70 over the last year, indicating some volatility. The stock's recent performance may attract attention as insiders are actively buying.
Analysts Set New Price Targets
Analysts maintain a strong outlook on AHR, with firms like UBS and Barclays keeping their ratings at 'Buy' and 'Overweight', respectively. UBS set a price target of $62.00, while Barclays adjusted its target to $60.00. The average target price among analysts is $64.40, reflecting optimism about the company's future.
What American Healthcare REIT, Inc. Does
American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT) that owns and operates healthcare facilities across the U.S., U.K., and the Isle of Man. The company's focus includes senior housing and skilled nursing facilities, making it a key player in the healthcare real estate sector.
What's Next for American Healthcare REIT, Inc.
Looking ahead, American Healthcare REIT is scheduled to report its next earnings on November 5, 2026. Investors will be watching for updates on its performance and any further insider trading activity. The recent purchases by insiders may signal confidence in the company's prospects.
Related Filing Alerts
Source: Smith Wilbur III's Form 4 filing on $AHR (Jun 24, 2026). Find the original filing: AHR Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts